Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term antithyroid treatment in hyperthyroidism

D W Slingerland, B A Burrows

    JAMA
    |November 30, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Long-term antithyroid drug treatment for hyperthyroidism can achieve a high remission rate (76%) and is safe and effective. A specific thyroid uptake test accurately predicts sustained remission after treatment cessation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Food-bound B12 absorption and serum total homocysteine in patients with low serum B12 levels.

    American journal of hematology·1998
    Same author

    Availability for absorption of egg yolk-bound cobalt-57-labeled vitamin B12 administered as an omelette or an eggnog.

    American journal of hematology·1993
    Same author

    Bound vitamin B12 absorption in patients with low serum B12 levels.

    American journal of hematology·1992
    Same author

    Cesium-137/potassium-40 ratios in firewood ashes as a reflection of worldwide radioactive contamination of the environment.

    Annals of the New York Academy of Sciences·1990
    Same author

    Further studies on the use of serum gastrin levels in assessing the significance of low serum B12 levels.

    American journal of hematology·1989
    Same author

    Physical activity as a supplement to a weight-loss dietary regimen.

    The American journal of clinical nutrition·1989
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology

    Background:

    • Hyperthyroidism treatment traditionally faces challenges with low remission rates using antithyroid compounds.
    • The efficacy and safety of long-term antithyroid drug therapy require further investigation.

    Purpose of the Study:

    • To evaluate the long-term efficacy and safety of continuous antithyroid drug treatment for hyperthyroidism.
    • To assess the remission rate and predictive accuracy of a prognostic test for sustained remission.

    Main Methods:

    • Eighty patients with hyperthyroidism received continuous antithyroid drug treatment for at least one year (average 4.4 years).
    • Follow-up averaged 7.8 years to assess remission status.
    • A prognostic test measuring thyroid uptake (<20%) was used to predict remission after treatment cessation.

    Related Experiment Videos

    Main Results:

    • A high remission rate of 76% was achieved with long-term treatment.
    • The prognostic test demonstrated approximately 75% accuracy in predicting continued remission.
    • Adverse events were infrequent, with mild reactions in 6% and hypothyroidism in 3% of patients.

    Conclusions:

    • Continuous, long-term antithyroid drug therapy is a safe and effective treatment for hyperthyroidism, yielding high remission rates.
    • The suppressed thyroid uptake test is a valuable tool for predicting the likelihood of sustained remission.